1. Home
  2. ARRY vs AUPH Comparison

ARRY vs AUPH Comparison

Compare ARRY & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARRY
  • AUPH
  • Stock Information
  • Founded
  • ARRY 1989
  • AUPH 1993
  • Country
  • ARRY United States
  • AUPH Canada
  • Employees
  • ARRY N/A
  • AUPH N/A
  • Industry
  • ARRY Semiconductors
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARRY Technology
  • AUPH Health Care
  • Exchange
  • ARRY Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • ARRY 785.6M
  • AUPH 1.1B
  • IPO Year
  • ARRY 2020
  • AUPH 1999
  • Fundamental
  • Price
  • ARRY $7.79
  • AUPH $7.59
  • Analyst Decision
  • ARRY Buy
  • AUPH Strong Buy
  • Analyst Count
  • ARRY 20
  • AUPH 2
  • Target Price
  • ARRY $9.47
  • AUPH $11.50
  • AVG Volume (30 Days)
  • ARRY 10.2M
  • AUPH 1.6M
  • Earning Date
  • ARRY 08-07-2025
  • AUPH 07-31-2025
  • Dividend Yield
  • ARRY N/A
  • AUPH N/A
  • EPS Growth
  • ARRY N/A
  • AUPH N/A
  • EPS
  • ARRY N/A
  • AUPH 0.27
  • Revenue
  • ARRY $1,064,767,000.00
  • AUPH $247,295,000.00
  • Revenue This Year
  • ARRY $23.50
  • AUPH $12.15
  • Revenue Next Year
  • ARRY $11.23
  • AUPH $18.31
  • P/E Ratio
  • ARRY N/A
  • AUPH $28.53
  • Revenue Growth
  • ARRY N/A
  • AUPH 29.20
  • 52 Week Low
  • ARRY $3.76
  • AUPH $5.20
  • 52 Week High
  • ARRY $12.06
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • ARRY 59.57
  • AUPH 40.36
  • Support Level
  • ARRY $5.68
  • AUPH $7.29
  • Resistance Level
  • ARRY $6.60
  • AUPH $8.86
  • Average True Range (ATR)
  • ARRY 0.64
  • AUPH 0.34
  • MACD
  • ARRY -0.03
  • AUPH -0.06
  • Stochastic Oscillator
  • ARRY 84.06
  • AUPH 19.37

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: